Recursion Gets FDA Approval to Begin Phase 1 Trials of AI-Discovered Cancer Treatment
Source: Recursion Pharmaceuticals Pioneer in AI drugs Recursion Pharmaceuticals said Wednesday that one of its experimental treatments has reached a…
Excientia PLC